Performance analysis of Cadrenal Therapeutics (CVKD)
Annual Return
Over the past 3 years, CVKD has had an average annual return of -51.29%, underperforming the benchmark SPY, which returned +19.31% annual.
Since Jan 20, 2023, CVKD has had an average annual return of -62.02%, underperforming the benchmark SPY, which returned +21.22% annual.
| 2026 | 2025 | 2024 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.19% | -53.22% | +30.57% | -82.04% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.55% | +22.13% | -39.74% | +30.31% | -25.58% | -32.75% | -37.41% | -69.19% | |||||
| 2025 | +36.42% | -3.91% | -7.19% | -6.87% | -18.82% | -9.60% | -13.54% | +24.38% | +6.72% | -1.21% | -31.30% | -27.78% | -53.22% |
| 2024 | +145.94% | -61.31% | -13.34% | -27.89% | +7.12% | -0.26% | -7.62% | +16.89% | +79.30% | +24.22% | -10.42% | -4.60% | +30.57% |
| 2023 | -32.52% | -28.42% | -29.15% | -4.97% | +6% | +6.32% | -43.71% | -9.40% | -11.66% | -35.19% | +4.39% | +60.79% | -82.04% |
Drawdown analysis of Cadrenal Therapeutics (CVKD)
The maximum drawdown for the CVKD was -96.62%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current CVKD drawdown is -96.62%.
Since Jan 20, 2023 CVKD has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.62% | Jan 20, 2023 | 875 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |